Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (COLL) Beats on EPS, Stock Up 3.27%

Collegium Pharmaceutical reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising by 3.27%. However, there was no revenue reported or guidance provided, leaving investors with limited insight into future performance. The stock's increase suggests that investors may be encouraged by the EPS surprise, despite the lack of additional information.